Human FUS is toxic via association with RNA polymerase II in Drosophila.

The RNA-binding protein FUS is commonly mutated in familial cases of amyotrophic lateral sclerosis (ALS-FUS), where it forms cytoplasmic inclusions. In addition, non-mutated FUS is a constituent component of protein inclusions in approximately 5-10% of cases of frontotemporal lobar degeneration (FTLD). Overexpression of wild-type human FUS is toxic to Drosophila neurons, preventing normal development and shortening lifespan in adults. In this study, we demonstrated that removal of the nuclear localisation sequence (NLS) of FUS, a common consequence of ALS-associated mutations, unexpectedly prevents toxicity in Drosophila models despite inducing FUS cytoplasmic mislocalisation. Using novel flies capable of expressing mGFP-tagged FUS, we found that FUS forms dynamic protein granules in Drosophila nuclei and does not form insoluble aggregates. FUS and other FET-family paralogues interact with the repetitive disordered C-terminal domain (CTD) of the large subunit of RNA polymerase II (Polr2A). Using flies that have variable CTD repeat lengths, we demonstrated that FUS genetically interacts with the Polr2A CTD to induce toxicity. Finally, we demonstrated that this association with Polr2A could be relevant to human disease, finding that inclusion-bearing neurons of individuals with FUS-positive FTLD, but not ALS-FUS, show cytoplasmic mislocalisation of POLR2A (the Polr2A human orthologue). Together, these results imply that FUS can have a nuclear mechanism of toxicity when overexpressed in animal models. This toxicity occurs via interaction with RNA polymerase II and aberrant interaction between FUS and POLR2A may be involved in the pathogenesis of FTLD.